KalVista Pharmaceuticals, Inc. (KALV) quarterly income statement — complete revenue, gross profit & net income history
| Metric | Q4'26 | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 |
|---|
| Sales/Revenue | 40.86M | 59.92M | 13.69M | 1.43M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Cost of Goods Sold | 3.44M | 3.98M | 1.23M | 590K | 15.89M | 0 | 0 | 0 | 25.25M | 207K | 19.09M | 19.31M | 23.95M | 20.06M | 18.08M | 18.19M | 19.21M | 0 | 0 | 0 |
| COGS % of Revenue | 8.43% | 6.64% | 9% | 41.37% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | 37.42M | 55.95M | 12.46M | 836K | -15.89M | 0 | 0 | 0 | -25.25M | -207K | -19.09M | -19.31M | -23.95M | -20.06M | -18.08M | -18.19M | -19.21M | 0 | 0 | 0 |
| Gross Margin % | 91.57% | 93.36% | 91% | 58.63% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | 335.47% | - | - | - | 37.06% | 100% | 100% | 100% | -5.42% | 98.97% | -5.6% | -6.16% | -24.66% | - | - | - | -61.77% | - | - | - |
| Operating Expenses | 60.86M | 67.46M | 58.51M | 59.84M | 39.14M | 42.94M | 45.81M | 44.22M | 23.21M | 32.94M | 10.66M | 9.79M | 7.78M | 6.88M | 7.81M | 8.13M | 7.6M | 26.68M | 23.6M | 19.52M |
| OpEx % of Revenue | 148.94% | 112.57% | 427.33% | 4196.7% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Selling, General & Admin | 48.44M | 58.61M | 46.52M | 44.68M | 39.14M | 30.35M | 29.2M | 17.6M | 23.21M | 10.42M | 10.66M | 9.79M | 7.78M | 6.88M | 7.81M | 8.13M | 7.6M | 6.95M | 6.06M | 5.85M |
| SG&A % of Revenue | 118.54% | 97.81% | 339.74% | 3133.45% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Research & Development | 12.42M | 8.85M | 11.99M | 15.16M | 15.89M | 12.59M | 16.61M | 26.61M | 25.25M | 22.52M | 19.09M | 19.31M | 23.95M | 20.06M | 18.08M | 18.19M | 19.21M | 19.74M | 17.55M | 13.67M |
| R&D % of Revenue | 30.39% | 14.77% | 87.59% | 1063.25% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 0 | 0 | 0 | 0 | -1000K | 0 | 0 | 0 | -1000K | 0 | -1000K | -1000K | -1000K | -1000K | -1000K | -1000K | -1000K | 0 | 0 | 0 |
| Operating Income | -23.44M | -11.51M | -46.05M | -59.01M | -55.03M | -42.94M | -45.81M | -44.22M | -48.45M | -33.15M | -29.75M | -29.09M | -31.73M | -26.95M | -25.88M | -26.32M | -26.81M | -26.68M | -23.6M | -19.52M |
| Operating Margin % | -57.37% | -19.21% | -336.33% | -4138.08% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Income Growth % | 57.4% | 73.19% | -0.52% | -33.46% | -13.57% | -29.53% | -54.01% | -51.98% | -52.72% | -23.03% | -14.92% | -10.55% | -18.34% | -0.98% | -9.66% | -34.84% | -48.6% | -110.82% | -84.67% | -35.12% |
| EBITDA | -23.09M | -10.93M | -45.68M | -58.76M | -54.77M | -42.71M | -45.58M | -43.99M | -48.24M | -32.94M | -29.55M | -28.9M | -31.54M | -26.75M | -25.71M | -26.16M | -26.66M | -26.53M | -23.48M | -19.38M |
| EBITDA Margin % | -56.5% | -18.23% | -333.63% | -4120.41% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA Growth % | 57.85% | 74.42% | -0.21% | -33.57% | -13.54% | -29.65% | -54.27% | -52.22% | -52.94% | -23.17% | -14.93% | -10.48% | -18.33% | -0.8% | -9.52% | -34.95% | -48.89% | -111.92% | -85.61% | -35.41% |
| D&A (Non-Cash Add-back) | 355K | 586.5K | 369K | 252K | 261K | 229K | 227K | 224K | 219K | 207K | 197K | 193K | 188K | 199K | 173K | 158K | 156K | 149K | 127K | 132K |
| EBIT | -23.44M | -11.51M | -42.57M | -54.42M | -55.03M | -41.42M | -45.81M | -44.22M | -48.45M | -33.15M | -29.75M | -29.09M | -31.73M | -26.95M | -25.88M | -26.32M | -26.81M | -26.68M | -23.6M | -19.52M |
| Net Interest Income | -3.04M | -5.28M | -2.88M | -1.67M | -951K | -1.45M | 1.36M | 1.69M | 1.51M | 684K | 776K | 923K | 808K | 732K | 449K | 242K | 268K | 258K | 290K | 274K |
| Interest Income | 2.55M | 3.37M | 1.88M | 1.85M | 1.99M | 1.39M | 1.36M | 1.69M | 1.51M | 684K | 776K | 923K | 808K | 732K | 449K | 242K | 268K | 258K | 290K | 274K |
| Interest Expense | 5.59M | 8.65M | 4.76M | 3.52M | 2.94M | 2.84M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | -45K | -959K | -1.27M | 1.07M | 1.95M | -1.32M | 3.54M | 3.77M | 3.81M | 4.12M | 2.1M | 3.78M | 5.42M | 5.64M | 3.63M | 3.27M | 2.7M | 4.22M | 3.95M | 3.41M |
| Pretax Income | -23.49M | -12.47M | -47.33M | -57.94M | -53.08M | -44.26M | -42.27M | -40.44M | -44.65M | -29.03M | -27.65M | -25.32M | -26.3M | -21.3M | -22.26M | -23.04M | -24.11M | -22.47M | -19.65M | -16.11M |
| Pretax Margin % | -57.48% | -20.81% | -345.64% | -4063.04% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Income Tax | 0 | -7.1M | 2.16M | 2.16M | -855K | 4.25M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 56.92% | -4.56% | -3.72% | 1.61% | -9.6% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -23.49M | -5.37M | -49.48M | -60.1M | -52.23M | -48.51M | -42.27M | -40.44M | -44.65M | -29.03M | -27.65M | -25.32M | -26.3M | -21.3M | -22.26M | -23.04M | -24.11M | -22.47M | -19.65M | -16.11M |
| Net Margin % | -57.48% | -8.96% | -361.39% | -4214.31% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Income Growth % | 55.03% | 88.93% | -17.07% | -48.59% | -16.97% | -67.11% | -52.87% | -59.75% | -69.74% | -36.26% | -24.23% | -9.87% | -9.09% | 5.18% | -13.27% | -43.04% | -61.23% | -123.6% | -88.47% | -48.96% |
| Net Income (Continuing) | -23.49M | -5.37M | -49.48M | -60.1M | -52.23M | -48.51M | -42.27M | -40.44M | -44.65M | -29.03M | -27.65M | -25.32M | -26.3M | -21.3M | -22.26M | -23.04M | -24.11M | -22.47M | -19.65M | -16.11M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -1.08 | -0.11 | -0.92 | -1.12 | -1.05 | -0.92 | -0.91 | -0.87 | -1.02 | -0.84 | -0.80 | -0.74 | -1.17 | -0.51 | -0.75 | -0.94 | -0.90 | -0.92 | -0.80 | -0.66 |
| EPS Growth % | -2.86% | 88.04% | -1.1% | -28.74% | -2.94% | -9.52% | -13.75% | -17.57% | 12.82% | -64.71% | -6.67% | 21.28% | -30% | 44.57% | 6.25% | -42.42% | -38.46% | -64.29% | -37.93% | -8.2% |
| EPS (Basic) | -1.08 | -0.11 | -0.92 | -1.12 | -1.05 | -0.92 | -0.91 | -0.87 | -1.02 | -0.84 | -0.80 | -0.74 | -1.17 | -0.51 | -0.75 | -0.94 | -0.90 | -0.92 | -0.80 | -0.66 |
| Diluted Shares Outstanding | 50.9M | 50.54M | 53.88M | 53.5M | 49.65M | 52.64M | 46.7M | 46.23M | 43.59M | 34.72M | 34.57M | 34.41M | 34.34M | 28.28M | 24.6M | 24.56M | 24.55M | 24.48M | 24.44M | 24.43M |
| Basic Shares Outstanding | 50.9M | 50.54M | 53.88M | 53.5M | 49.65M | 52.64M | 46.7M | 46.23M | 43.59M | 34.72M | 34.57M | 34.41M | 34.34M | 28.28M | 24.6M | 24.56M | 24.54M | 24.48M | 24.44M | 24.43M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |